HOSMAC Launches Urban Health Data Platform to Enable Smarter Healthcare Planning and Investment

IMT News Desk
IMT News Desk
· 3 min read
HOSMAC, Urban Health Data Platform, UHDP, health mapping, cancer care infrastructure, hospital planning, healthcare analytics, investment decisions, patient catchment, India healthcare, urban health, data-driven planning

HOSMAC, one of India’s leading hospital consulting firms, has launched the Urban Health Data Platform (UHDP), a research-driven digital platform aimed at helping healthcare stakeholders better understand India’s healthcare infrastructure through interactive mapping and analytics. Developed over several years of research, data validation and growing computational expertise, the beta version allows users to map hospitals by ownership and geographical location, offering insights to support healthcare planning, policy formulation, research and investment decisions.

The beta release focuses on cancer care infrastructure across India, mapping nearly 700 government-, trust-owned and private cancer hospitals. In addition to locating facilities, the platform analyses patient catchment areas based on travel distance and road connectivity, helping identify well-served and underserved regions. Users can also access demographic and socio-economic information, including population data, hospital ownership patterns and regional healthcare coverage, enabling more evidence-based planning and resource allocation.

A key strength of the UHDP is its ability to simulate infrastructure planning. Users can virtually add a proposed hospital at a chosen location and immediately assess its potential impact on accessibility and patient catchments. For example, an analysis of the Nanded region in Maharashtra suggests that establishing a government cancer hospital in the district could substantially improve access for underserved populations currently travelling over 200 kilometres for treatment, while easing the load on neighbouring facilities.

The platform also provides comparative insights across major metropolitan areas. Early analysis indicates that Kolkata has one of the largest cancer care catchments by population, reflecting that many patients travel long distances to receive treatment, whereas Chennai shows a more compact catchment supported by a relatively well-distributed cancer care network. Similarly, cities such as Mumbai and Delhi benefit from surrounding satellite cities that collectively enhance regional healthcare accessibility.

Commenting on the launch, Dr Vivek Desai, Founder and Managing Director, HOSMAC, said, “The Urban Health Data Platform reflects our commitment to democratising healthcare intelligence and empowering stakeholders with meaningful, research-backed insights. India requires data-driven healthcare planning now more than ever. By making validated healthcare information accessible through an interactive platform, we hope to support better investment decisions, stronger healthcare delivery systems, and more equitable access to care.”

HOSMAC plans to continuously expand the UHDP by adding new healthcare datasets, hospital typologies and analytical capabilities. Future versions are expected to incorporate variables such as hospital capacity, affordability, medical equipment, treatment costs, demographic trends, government empanelment and care pathways, building a comprehensive decision-support platform for India’s evolving healthcare ecosystem.

Designed for hospital owners, healthcare administrators, consultants, policymakers, researchers, investors and public health professionals, the Urban Health Data Platform reflects HOSMAC’s ongoing commitment to advancing healthcare through research, innovation and knowledge-driven planning.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk